Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TYMS Antikörper (AA 60-174)

Der Maus Monoklonal Anti-TYMS-Antikörper wurde für IHC (p) validiert. Er ist geeignet, TYMS in Proben von Human zu detektieren.
Produktnummer ABIN5646952

Kurzübersicht für TYMS Antikörper (AA 60-174) (ABIN5646952)

Target

Alle TYMS Antikörper anzeigen
TYMS (Thymidylate Synthetase (TYMS))

Reaktivität

  • 119
  • 29
  • 15
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 65
  • 53
  • 1
Maus

Klonalität

  • 73
  • 46
Monoklonal

Konjugat

  • 54
  • 9
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TYMS Antikörper ist unkonjugiert

Applikation

  • 64
  • 57
  • 55
  • 35
  • 25
  • 19
  • 19
  • 16
  • 14
  • 13
  • 13
  • 10
  • 7
  • 7
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

TYMS-1884
  • Bindungsspezifität

    • 25
    • 15
    • 13
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 60-174

    Produktmerkmale

    This antibody recognizes a protein of 36 kDa, identified as Thymidylate Synthase (TS, TYMS). TS converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.

    Aufreinigung

    Purified

    Reinheit

    Protein G affinity chromatography

    Immunogen

    A recombinant human parital protein corresponding to amino acids 60-174 was used as the immunogen for this TYMS antibody.

    Isotyp

    IgG2a kappa
  • Applikationshinweise

    The optimal dilution of the TYMS antibody for each application should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the TYMS antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    TYMS (Thymidylate Synthetase (TYMS))

    Andere Bezeichnung

    Thymidylate Synthase

    Hintergrund

    This antibody recognizes a protein of 36  kDa, identified as Thymidylate Synthase (TS, TYMS). TS converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.

    Pathways

    Mitotic G1-G1/S Phases
Sie sind hier:
Chat with us!